{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:13:30Z","timestamp":1792181610660,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.amjoto.2024.104275","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T16:30:46Z","timestamp":1711729846000},"page":"104275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dupilumab's impact on nasal citology: Real life experience after 1\u00a0year of treatment"],"prefix":"10.1016","volume":"45","author":[{"given":"Matteo","family":"Gelardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Giancaspro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliano Nicola","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"La Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2024.104275_bb0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40259-023-00602-9","article-title":"The role of biologics in the treatment of chronic rhinosinusitis","volume":"37","author":"Haloob","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.amjoto.2024.104275_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40463-023-00668-z","article-title":"The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)","volume":"52","author":"Hardison","year":"2023","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2024.104275_bb0015","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/all.15796","article-title":"Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6months","volume":"78","author":"van der Lans","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12016-022-08934-0","article-title":"Dupilumab-associated adverse events during treatment of allergic diseases","volume":"62","author":"Kychygina","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0025","doi-asserted-by":"crossref","first-page":"4027701","DOI":"10.1155\/2023\/4027701","article-title":"Dupilumab\u2019s impact on blood parameters in nasal polyposis: 18-month follow-up in real life","volume":"2023","author":"Loperfido","year":"2023","journal-title":"J Immunol Res"},{"key":"10.1016\/j.amjoto.2024.104275_bb0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/1744666X.2023.2218617","article-title":"Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making","volume":"19","author":"Otten","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0035","unstructured":"Papacharalampous, G. X. et al. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare agents' efficacy. Int Forum Allergy Rhinol n\/a,."},{"key":"10.1016\/j.amjoto.2024.104275_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.14639\/0392-100X-N2156","article-title":"A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation","volume":"42","author":"Trimarchi","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.amjoto.2024.104275_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.768408","article-title":"Nasal cytology: a easy diagnostic tool in precision medicine for inflammation in epithelial barrier damage in the nose. A perspective mini review","volume":"3","author":"Caruso","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0050","first-page":"e2023227","article-title":"Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a bicentric experience","volume":"94","author":"Bellocchi","year":"2023","journal-title":"Acta Biomedica Atenei Parmensis"},{"key":"10.1016\/j.amjoto.2024.104275_bb0055","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational Phase IV real-life study (DUPIREAL)","volume":"78","author":"De Corso","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14639\/0392-100X-N0364","article-title":"Prognostic value of the sinonasal outcome test 22 (SNOT-22) in chronic rhinosinusitis","volume":"40","author":"Gallo","year":"2020","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.amjoto.2024.104275_bb0065","article-title":"Correlation between chronic rhinosinusitis with nasal polyposis (CRSwNP) severity and asthma control","volume":"44","author":"Gelardi","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0070","doi-asserted-by":"crossref","DOI":"10.4193\/Rhin22.011","article-title":"Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis","author":"Jeong","year":"2022","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104275_bb0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/cea.12730","article-title":"NASAL cytology: practical aspects and clinical relevance","volume":"46","author":"Gelardi","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0080","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/cea.13207","article-title":"Nasal cytology: Methodology with application to clinical practice and research","volume":"48","author":"Heffler","year":"2018","journal-title":"Clin Experimental Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0085","doi-asserted-by":"crossref","unstructured":"Gelardi, M., Russo, C., Fiorella, M. L., Fiorella, R. & Ciprandi, G. Inflammatory cell types in nasal polyps. Cytopathology vol. 21 201\u2013203 Preprint at doi:https:\/\/doi.org\/10.1111\/j.1365-2303.2009.00671.x (2010).","DOI":"10.1111\/j.1365-2303.2009.00671.x"},{"key":"10.1016\/j.amjoto.2024.104275_bb0090","doi-asserted-by":"crossref","unstructured":"Gelardi, M., Landi, M. & Ciprandi, G. Nasal cytology: a Precision Medicine tool in clinical practice. Clinical and Experimental Allergy vol. 48 96\u201397 Preprint at doi:https:\/\/doi.org\/10.1111\/cea.13065 (2018).","DOI":"10.1111\/cea.13065"},{"key":"10.1016\/j.amjoto.2024.104275_bb0095","article-title":"Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study","author":"La Mantia","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-224756","article-title":"Dupilumab for relapsing or refractory sinonasal and\/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study","author":"Molina","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjoto.2024.104275_bb0105","doi-asserted-by":"crossref","first-page":"1127576","DOI":"10.3389\/fimmu.2023.1127576","article-title":"Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab","volume":"14","author":"Danisman","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000514262","article-title":"Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis","volume":"182","author":"Meier","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104275_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40463-023-00663-4","article-title":"The \u2018real life\u2019 efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP","volume":"52","author":"Campion","year":"2023","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2024.104275_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-022-00171-2","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life","volume":"20","author":"Nettis","year":"2022","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0130","article-title":"Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG)","volume":"19458924211049867","author":"Gelardi","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.amjoto.2024.104275_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14639\/0392-100X-N1699","article-title":"Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice","volume":"42","author":"Gelardi","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.amjoto.2024.104275_bb0140","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/jpm13091404","article-title":"Targeting IL-4 and IL-13 receptors on eosinophils in CRSwNP patients: the clinical efficacy of Dupilumab","volume":"13","author":"Piazzetta","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.amjoto.2024.104275_bb0145","first-page":"7324","article-title":"Severe chronic rhinosinusitis treated with dupilumab, a real-life analysis of early effectiveness","volume":"27","author":"Mocellin","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.amjoto.2024.104275_bb0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12890-023-02556-8","article-title":"Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?","volume":"23","author":"Al-Ahmad","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.amjoto.2024.104275_bb0155","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1038\/s41598-023-39149-8","article-title":"Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP","volume":"13","author":"Gelardi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjoto.2024.104275_bb0160","article-title":"Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52","author":"Bachert","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/194589240301700503","article-title":"Nasal cytology: description of a hyperchromatic supranuclear stria as a possible marker for the anatomical and functional integrity of the ciliated cell","volume":"17","author":"Gelardi","year":"2003","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0170","first-page":"151","article-title":"State-of-the-art overview on biological treatment for CRSwNP","volume":"59","author":"Hellings","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.amjoto.2024.104275_bb0175","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaip.2021.09.037","article-title":"Olfactory outcomes with Dupilumab in chronic rhinosinusitis with nasal polyps","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjoto.2024.104275_bb0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14639\/0392-100X-2426","article-title":"Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity","volume":"39","author":"Gelardi","year":"2019","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.amjoto.2024.104275_bb0185","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.3390\/ijms22137075","article-title":"Emerging evidence for pleiotropism of eosinophils","volume":"22","author":"Rodrigo-Mu\u00f1oz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjoto.2024.104275_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121191","article-title":"Eosinophils: focus on DNA extracellular traps","volume":"311","author":"Thompson-Souza","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.amjoto.2024.104275_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","article-title":"Pattern-recognition receptors in human eosinophils","volume":"136","author":"Kvarnhammar","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.amjoto.2024.104275_bb0200","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.3390\/ijms22158004","article-title":"Eosinophils and bacteria, the beginning of a story","volume":"22","author":"Ondari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjoto.2024.104275_bb0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.it.2019.05.001","article-title":"The healing power of neutrophils","volume":"40","author":"Phillipson","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.amjoto.2024.104275_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006821.pub2","article-title":"Saline nasal irrigation for acute upper respiratory tract infections","volume":"CD006821","author":"Kassel","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjoto.2024.104275_bb0215","article-title":"Chronic rhinosinusitis with nasal polyps recurrence: not only eosinophils and neutrophils","volume":"103447","author":"Gelardi","year":"2022","journal-title":"Am J Otolaryngol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070924000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070924000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:20:50Z","timestamp":1742178050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070924000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0196070924000619"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104275","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab's impact on nasal citology: Real life experience after 1\u00a0year of treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2024.104275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104275"}}